Table 3 Procedure characteristics
Patients | Overall | High-risk | Low-risk | P value |
|---|---|---|---|---|
Aorta-iliac | 4 | 1 | 3 | |
TASC II A/B | 3 | 1 (100) | 2 (66.7) | 0.410 |
TASC II C/D | 1 | 0 (0) | 1 (33.3) | 0.410 |
Femoropopliteal | 41 | 14 | 27 | |
GLASS stage 1/2 | 22 | 5 (35.7) | 17 (63.0) | 0.096 |
GLASS stage 3/4 | 19 | 9 (64.3) | 10 (37.0) | 0.096 |
Number of EVTs | 1.15 ± 0.42 | 1.07 ± 0.27 | 1.29 ± 0.61 | 0.129 |
Use of DCBs | 30 | 10 (33.3) | 20 (66.7) | 0.857 |
Use of scaffold devices | 11 | 4 (36.4) | 7 (63.6) | 0.857 |
Below-the-knee | 37 | 12 | 25 | |
GLASS stage 1/2 | 16 | 2 (16.7) | 14 (56.0) | 0.019 |
GLASS stage 3/4 | 21 | 10 (83.3) | 11 (44.0) | 0.019 |
Number of EVTs | 1.27 ± 0.69 | 1.67 ± 0.98 | 1.08 ± 0.40 | 0.014 |